The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
AffiliationSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital and University of Witwatersrand, Johannesburg, South Africa Red Cross Children's Hospital and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa Wits Reproductive Health and HIV Institute (Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto), Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa Médecins Sans Frontières South Africa and Khayelitsha ART Programme, Khayelitsha, Cape Town, South Africa Sinikithemba Clinic, McCord Hospital, Durban, South Africa Gugulethu Community Health Centre and Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
MetadataShow full item record
AbstractObjectives To determine the improvement in positive predictive value of immunological failure criteria for identifying virological failure in HIV-infected children on antiretroviral therapy (ART) when a single targeted viral load measurement is performed in children identified as having immunological failure. Methods Analysis of data from children (<16 years at ART initiation) at South African ART sites at which CD4 count/per cent and HIV-RNA monitoring are performed 6-monthly. Immunological failure was defined according to both WHO 2010 and United States Department of Health and Human Services (DHHS) 2008 criteria. Confirmed virological failure was defined as HIV-RNA >5000 copies/ml on two consecutive occasions <365 days apart in a child on ART for ≥18 months. Results Among 2798 children on ART for ≥18 months [median (IQR) age 50 (21-84) months at ART initiation], the cumulative probability of confirmed virological failure by 42 months on ART was 6.3%. Using targeted viral load after meeting DHHS immunological failure criteria rather than DHHS immunological failure criteria alone increased positive predictive value from 28% to 82%. Targeted viral load improved the positive predictive value of WHO 2010 criteria for identifying confirmed virological failure from 49% to 82%. Conclusion The addition of a single viral load measurement in children identified as failing immunologically will prevent most switches to second-line treatment in virologically suppressed children.
- Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
- Authors: Davies MA, Boulle A, Eley B, Moultrie H, Technau K, Rabie H, van Cutsem G, Giddy J, Wood R, Egger M, Keiser O, International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA‐SA) Collaboration.
- Issue date: 2011 Nov
- Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
- Authors: Salazar-Vizcaya L, Keiser O, Karl Technau, Davies MA, Haas AD, Blaser N, Cox V, Eley B, Rabie H, Moultrie H, Giddy J, Wood R, Egger M, Estill J
- Issue date: 2014 Oct 23
- Performance of immunological response in predicting virological failure.
- Authors: Ingole N, Mehta P, Pazare A, Paranjpe S, Sarkate P
- Issue date: 2013 Mar
- Detecting virological failure in HIV-infected Tanzanian children.
- Authors: Mgelea EM, Kisenge R, Aboud S
- Issue date: 2014 Jun 26
- Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
- Authors: Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, Wood R
- Issue date: 2007